# BUMETANIDE
> **ANDA216434** · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2022-05-26
## Drug
- **FDA Application Number:** ANDA216434
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUMETANIDE
- **Generic name:** BUMETANIDE
- **Active ingredients:** BUMETANIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** GLAND
- **Manufacturer:** GLENMARK PHARMACEUTICALS INC., USA
- **First approval:** 2022-05-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216434)
---
*AI Analytics · CC0 1.0*